BioLineRx Ltd (BLRX) — Strategic Asset Allocation Index
BioLineRx Ltd (BLRX) has a Strategic Asset Allocation Index of 10.6% as of June 2023. Strategic assets (PP&E of $2.23 Million plus long-term investments of $-) total $2.23 Million, measured against net assets of $21.05 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
BioLineRx Ltd Strategic Asset Allocation Index (2010–2021)
This chart shows how BioLineRx Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2010 to 2021. As of June 2023, the index stands at 10.6%, representing strategic assets of $2.23 Million against net assets of $21.05 Million USD. Explore BLRX cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for BioLineRx Ltd (2010–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for BioLineRx Ltd from 2010 to 2021, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BLRX market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.4% | $2.28 Million | $2.28 Million | $- | $68.09 Million | ▼ -8.9 pp |
| 2020 | 12.2% | $2.70 Million | $2.70 Million | $- | $22.03 Million | ▲ +1.9 pp |
| 2019 | 10.4% | $3.47 Million | $3.47 Million | $- | $33.38 Million | ▲ +5.0 pp |
| 2018 | 5.4% | $2.23 Million | $2.23 Million | $0.00 | $41.32 Million | ▼ -1.2 pp |
| 2017 | 6.6% | $3.50 Million | $2.50 Million | $1.00 Million | $52.88 Million | ▼ -0.8 pp |
| 2016 | 7.4% | $2.60 Million | $2.60 Million | $- | $35.03 Million | ▲ +1.3 pp |
| 2015 | 6.1% | $2.91 Million | $2.91 Million | $- | $47.61 Million | ▲ +3.8 pp |
| 2014 | 2.3% | $718.00K | $718.00K | $- | $31.77 Million | ▼ -3.8 pp |
| 2013 | 6.1% | $710.00K | $710.00K | $- | $11.68 Million | ▲ +0.4 pp |
| 2012 | 5.7% | $852.00K | $852.00K | $- | $14.97 Million | ▲ +0.8 pp |
| 2011 | 4.9% | $1.11 Million | $1.11 Million | $- | $22.53 Million | ▲ +1.5 pp |
| 2010 | 3.4% | $1.27 Million | $1.27 Million | $- | $37.26 Million | — |